{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:24:27Z","timestamp":1758846267104,"version":"3.44.0"},"reference-count":99,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Dermatol Surg","DS"],"published-print":{"date-parts":[[2025,10]]},"abstract":"<jats:sec>\n            <jats:title>BACKGROUND<\/jats:title>\n            <jats:p>Over the past five decades, dermatologic oncology has evolved with advances in both diagnosis and treatment of common and rare cutaneous malignancies. Melanoma, basal cell carcinoma (BCC), and cutaneous squamous cell carcinoma (cSCC) are the most frequently studied skin cancers, while in recent years, there is increasing attention on rarer tumors such as Merkel cell carcinoma (MCC), extramammary Paget disease (EMPD), and dermatofibrosarcoma protuberans (DFSP). As the field has grown, <jats:italic toggle=\"yes\">Dermatologic Surgery<\/jats:italic> (<jats:italic toggle=\"yes\">DS<\/jats:italic>) has been at the forefront of shaping and reflecting these developments.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>OBJECTIVE<\/jats:title>\n            <jats:p>The authors' purpose in this article was to explore the numerous historical advancements in dermatologic oncology. The authors primarily focus on the three most common cutaneous tumors: BCC, cSCC, and melanoma, but the authors also cover in less detail three rare tumors: MCC, DFSP, and EMPD. The authors highlight the role of DS in this evolution.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>MATERIALS AND METHODS<\/jats:title>\n            <jats:p>To identify studies to include or consider for this rapid review of the literature on the history of melanoma, BCC, cSCC, MCC, EMPD, and DFSP, the research team reviewed search terms to verify accuracy and relevance. One author (ET) developed a separate search strategy for each database in the methodology of a rapid review, aiming to accelerate evidence synthesis by streamlining traditional systematic review methods. The author searched the PubMed database (1975\u2013present) and the DS database using the advanced search function. All database searches were conducted on February 25, 2025, and rerun on April 20, 2025. Each search included \u201cdermatologic surgery\u201d to specifically isolate dermatologic oncology in the dermatologic surgery literature. The full search strategies are provided in <jats:bold>Supplemental Digital Content 1<\/jats:bold>, Appendices A and B, http:\/\/links.lww.com\/DSS\/B734. <jats:bold>Supplemental Digital Content 2<\/jats:bold>, Appendix B, http:\/\/links.lww.com\/DSS\/B734 searches were further separated into each year from 1975 to 2025.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>RESULTS<\/jats:title>\n            <jats:p>Between 1975 and April 20, 2025, there are 2,258 articles on PubMed related to Melanoma, and DS contains 602 of those articles (26.5%). There are 3,072 articles on PubMed for BCC, and of these, 164 are in DS (5.3%). There are 2,737 articles for cSCC on PubMed, and DS has published 129 (4.7%). Similarly, for MCC, EMPD, and DFSP, the total number of published articles since 1975 is 187, 186, and 359, respectively. <jats:italic toggle=\"yes\">Dermatologic Surgery<\/jats:italic> has contributed 21 (11.2%), 19 (10.2%), and 87 (24.2%) of those articles for MCC, EMPD, and DFSP, respectively.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSION<\/jats:title>\n            <jats:p>\n                                 <jats:italic toggle=\"yes\">Dermatologic Surgery<\/jats:italic> has played an important role in the evolution of dermatologic oncology, both by advancing the field and serving as a key platform for disseminating research. Over the past 50 years, the scope of research has expanded and shifted to explore new areas of study, accompanied by a significant rise in the volume of publications.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/dss.0000000000004871","type":"journal-article","created":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T12:03:05Z","timestamp":1757592185000},"page":"919-929","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Dermatologic Oncology: The Past 50 Years"],"prefix":"10.1097","volume":"51","author":[{"given":"Erika","family":"Tvedten","sequence":"first","affiliation":[{"name":"Departments of Dermatology and Dermatologic Surgery, Cooper University Hospital, Camden, NJ;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tara","family":"Jennings","sequence":"additional","affiliation":[{"name":"Departments of Dermatology and Dermatologic Surgery, Cooper University Hospital, Camden, NJ;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Murad","family":"Alam","sequence":"additional","affiliation":[{"name":"Departments of Dermatology and Dermatologic Surgery, Northwestern Medicine Feinberg School of Medicine, Chicago, IL;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Carr","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Dermatologic Surgery, Ohio State University, Columbus, OH;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Carucci","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Dermatologic Surgery, New York University, New York City, NY;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurin","family":"Council","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Dermatologic Surgery, Washington University in St. Louis, St. Louis, MO;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Eisen","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Dermatologic Surgery, University of California, Davis, CA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naomi","family":"Lawrence","sequence":"additional","affiliation":[{"name":"Departments of Dermatology and Dermatologic Surgery, Cooper University Hospital, Camden, NJ;"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2025,9,11]]},"reference":[{"key":"R1-20250925","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1097\/DSS.0000000000004002","article-title":"The controversy and value of Mohs micrographic surgery for melanoma and melanoma in situ on the trunk and extremities","volume":"49","author":"Zitelli","year":"2023","journal-title":"Dermatol Surg"},{"key":"R2-20250925","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1111\/j.1524-4725.1990.tb00022.x","article-title":"Mohs micrographic surgery fixed-tissue technique for melanoma of the nose","volume":"16","author":"Mohs","year":"1990","journal-title":"J Dermatol Surg Oncol"},{"key":"R3-20250925","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/S0190-9622(97)80131-4","article-title":"Mohs micrographic surgery for the treatment of primary cutaneous melanoma","volume":"37","author":"Zitelli","year":"1997","journal-title":"J Am Acad Dermatol"},{"key":"R4-20250925","first-page":"656","article-title":"Mohs micrographic surgery for melanoma: a case series, a comparative study of immunostains, an informative case report, and a unique mapping technique","volume":"28","author":"Albertini","year":"2002","journal-title":"Dermatol Surg"},{"key":"R5-20250925","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/j.1524-4725.2011.02005.x","article-title":"The operative management of melanoma: where does Mohs surgery fit in?","volume":"37","author":"Chang","year":"2011","journal-title":"Dermatol Surg"},{"key":"R6-20250925","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1097\/DSS.0000000000003435","article-title":"Recurrence rate for melanoma excised by Mohs micrographic surgery without immunostaining","volume":"48","author":"Vieira","year":"2022","journal-title":"Dermatol Surg"},{"key":"R7-20250925","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1097\/DSS.0000000000003268","article-title":"Systematic review of technical variations for Mohs Micrographic Surgery for melanoma","volume":"47","author":"Krausz","year":"2021","journal-title":"Dermatol Surg"},{"key":"R8-20250925","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1001\/jamadermatol.2016.6138","article-title":"Outcomes of melanoma in situ treated with Mohs micrographic surgery compared with wide local excision","volume":"153","author":"Nosrati","year":"2017","journal-title":"JAMA Dermatol"},{"key":"R9-20250925","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1097\/DSS.0000000000003309","article-title":"Local recurrence of melanoma is higher after wide local excision versus Mohs micrographic surgery or staged excision: a systematic review and meta-analysis","volume":"48","author":"Pride","year":"2022","journal-title":"Dermatol Surg"},{"key":"R10-20250925","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1001\/jamadermatol.2019.2622","article-title":"Improving survival for patients with early-stage melanoma","volume":"155","author":"Maher","year":"2019","journal-title":"JAMA Dermatol"},{"key":"R11-20250925","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jaad.2019.08.059","article-title":"Improved overall survival of melanoma of the head and neck treated with Mohs micrographic surgery versus wide local excision","volume":"82","author":"Hanson","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"R12-20250925","first-page":"403","article-title":"Immunostaining melanoma frozen sections: the 1-hour protocol","volume":"30","author":"Bricca","year":"2004","journal-title":"Dermatol Surg"},{"key":"R13-20250925","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1097\/DSS.0000000000000725","article-title":"Mohs micrographic surgery using MART-1 immunostain in the treatment of invasive melanoma and melanoma in situ","volume":"42","author":"Valentin-Nogueras","year":"2016","journal-title":"Dermatol Surg"},{"key":"R14-20250925","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.jaad.2015.01.007","article-title":"Low recurrence rates for in situ and invasive melanomas using Mohs micrographic surgery with melanoma antigen recognized by T cells 1 (MART-1) immunostaining: tissue processing methodology to optimize pathologic staging and margin assessment","volume":"72","author":"Etzkorn","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"R15-20250925","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1097\/DSS.0000000000004500","article-title":"Mart-1 during Mohs micrographic surgery for melanoma excision results in decreased stage number and decreased frequency of secondary pathologic consultation","volume":"51","author":"Zhang","year":"2025","journal-title":"Dermatol Surg"},{"key":"R16-20250925","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1097\/DSS.0000000000004312","article-title":"Mohs for melanoma: a review of MART-1 frozen section interpretation","volume":"50","author":"Contestable","year":"2024","journal-title":"Dermatol Surg"},{"key":"R17-20250925","doi-asserted-by":"crossref","first-page":"364","DOI":"10.6004\/jnccn.2021.0018","article-title":"NCCN guidelines insights: melanoma: cutaneous, version 2.2021","volume":"19","author":"Swetter","year":"2021","journal-title":"J Natl Compr Canc Netw"},{"key":"R18-20250925","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1001\/archsurg.1992.01420040034005","article-title":"Technical details of intraoperative lymphatic mapping for early stage melanoma","volume":"127","author":"Morton","year":"1992","journal-title":"Arch Surg"},{"key":"R19-20250925","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1056\/NEJMoa060992","article-title":"Sentinel-node biopsy or nodal observation in melanoma","volume":"355","author":"Morton","year":"2006","journal-title":"N Engl J Med"},{"key":"R20-20250925","first-page":"544","article-title":"Sentinel lymph node biopsy: an alternate view","volume":"34","author":"Zitelli","year":"2008","journal-title":"Dermatol Surg"},{"key":"R21-20250925","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/jso.21876","article-title":"Update on the melanoma staging system: the importance of sentinel node staging and primary tumor mitotic rate","volume":"104","author":"Balch","year":"2011","journal-title":"J Surg Oncol"},{"key":"R22-20250925","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.clindermatol.2012.08.004","article-title":"Sentinel lymph node biopsy for melanoma: a critical update for dermatologists after two decades of experience","volume":"31","author":"Ross","year":"2013","journal-title":"Clin Dermatol"},{"key":"R23-20250925","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1056\/NEJMoa1613210","article-title":"Completion dissection or observation for sentinel-node metastasis in melanoma","volume":"376","author":"Faries","year":"2017","journal-title":"N Engl J Med"},{"key":"R24-20250925","first-page":"22","article-title":"Wood's lamp and surgical margins in malignant melanoma in situ","volume":"14","author":"Reyes","year":"1988","journal-title":"J Dermatol Surg Oncol"},{"key":"R25-20250925","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1097\/DSS.0000000000000345","article-title":"Utility of Wood's light in margin determination of melanoma in situ after excisional biopsy","volume":"41","author":"Walsh","year":"2015","journal-title":"Dermatol Surg"},{"key":"R26-20250925","first-page":"101","article-title":"Long-term results of a prospective surgical trial comparing 2 cm vs. 4 cm excision margins for 740 patients with 1-4 mm melanomas","volume":"8","author":"Balch","year":"2001","journal-title":"Ann Surg Oncol"},{"key":"R27-20250925","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1097\/DSS.0000000000003926","article-title":"From centimeters to millimeters: the evolution of the surgical margins for melanoma-A historical review","volume":"49","author":"Rosenthal","year":"2023","journal-title":"Dermatol Surg"},{"key":"R28-20250925","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/DSS.0000000000003683","article-title":"Local recurrence rates of malignant melanoma after Mohs micrographic surgery are lowest with 5- to 10-mm initial margins: a systematic review and meta-analysis","volume":"49","author":"Campbell","year":"2023","journal-title":"Dermatol Surg"},{"key":"R29-20250925","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1097\/DSS.0000000000003699","article-title":"Local recurrence rates after excision of desmoplastic melanoma: a systematic review and meta-analysis","volume":"49","author":"Ran","year":"2023","journal-title":"Dermatol Surg"},{"key":"R30-20250925","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1001\/archderm.140.5.607","article-title":"Surgical margins for lentigo maligna, 2004","volume":"140","author":"Zitelli","year":"2004","journal-title":"Arch Dermatol"},{"key":"R31-20250925","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.jaad.2011.06.019","article-title":"Surgical margins for melanoma in situ","volume":"66","author":"Kunishige","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"R32-20250925","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1111\/j.1524-4725.2010.01560.x","article-title":"Treatment of lentigo maligna with imiquimod cream: a long-term follow-up study of 10 patients","volume":"36","author":"Van Meurs","year":"2010","journal-title":"Dermatol Surg"},{"key":"R33-20250925","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1345\/aph.1P651","article-title":"Ipilimumab: a novel treatment for metastatic melanoma","volume":"45","author":"Culver","year":"2011","journal-title":"Ann Pharmacother"},{"key":"R34-20250925","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1056\/NEJMoa1203421","article-title":"Improved survival with MEK inhibition in BRAF-mutated melanoma","volume":"367","author":"Flaherty","year":"2012","journal-title":"N Engl J Med"},{"key":"R35-20250925","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1056\/NEJMoa1210093","article-title":"Combined BRAF and MEK inhibition in melanoma with BRAF V600 mutations","volume":"367","author":"Flaherty","year":"2012","journal-title":"N Engl J Med"},{"key":"R36-20250925","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1001\/jama.2016.4059","article-title":"Association of pembrolizumab with tumor response and survival among patients with advanced melanoma","volume":"315","author":"Ribas","year":"2016","journal-title":"JAMA"},{"key":"R37-20250925","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1056\/NEJMoa1709030","article-title":"Adjuvant nivolumab versus ipilimumab in resected stage III or IV melanoma","volume":"377","author":"Weber","year":"2017","journal-title":"N Engl J Med"},{"key":"R38-20250925","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1524-4725.1984.tb00476.x","article-title":"Malignant melanoma prognostic factors 5: clinical staging","volume":"10","author":"Day","year":"1984","journal-title":"J Dermatol Surg Oncol"},{"key":"R39-20250925","doi-asserted-by":"crossref","first-page":"3622","DOI":"10.1200\/JCO.2001.19.16.3622","article-title":"Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system","volume":"19","author":"Balch","year":"2001","journal-title":"J Clin Oncol"},{"key":"R40-20250925","doi-asserted-by":"crossref","first-page":"4108","DOI":"10.1002\/cncr.29634","article-title":"Revisiting determinants of prognosis in cutaneous melanoma","volume":"121","author":"Weiss","year":"2015","journal-title":"Cancer"},{"key":"R41-20250925","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1056\/NEJMoa1802357","article-title":"Adjuvant pembrolizumab versus placebo in resected stage III melanoma","volume":"378","author":"Eggermont","year":"2018","journal-title":"N Engl J Med"},{"key":"R42-20250925","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1001\/archderm.134.8.983","article-title":"Prediction of sentinel lymph node micrometastasis by histological features in primary cutaneous malignant melanoma","volume":"134","author":"Mraz-Gernhard","year":"1998","journal-title":"Arch Dermatol"},{"key":"R43-20250925","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/CMR.0b013e3282f2017d","article-title":"Postoperative morbidity of lymph node excision for cutaneous melanoma-sentinel lymphonodectomy versus complete regional lymph node dissection","volume":"18","author":"Kretschmer","year":"2008","journal-title":"Melanoma Res"},{"key":"R44-20250925","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1001\/archderm.137.10.1343","article-title":"Is dermoscopy (epiluminescence microscopy) useful for the diagnosis of melanoma? Results of a meta-analysis using techniques adapted to the evaluation of diagnostic tests","volume":"137","author":"Bafounta","year":"2001","journal-title":"Arch Dermatol"},{"key":"R45-20250925","first-page":"343","article-title":"Analysis of the benign to malignant ratio of lesions biopsied by a general dermatologist before and after the adoption of dermoscopy","volume":"146","author":"Terushkin","year":"2010","journal-title":"Arch Dermatol"},{"key":"R46-20250925","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s42047-024-00171-3","article-title":"PRAME immunohistochemistry distinguishes nodal nevi from metastatic melanoma","volume":"7","author":"da Silveira","year":"2024","journal-title":"Surg Exp Pathol"},{"key":"R47-20250925","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1038\/s41379-020-0490-7","article-title":"Through the looking glass and what you find there: making sense of comparative genomic hybridization and fluorescence in situ hybridization for melanoma diagnosis","volume":"33","author":"Miedema","year":"2020","journal-title":"Mod Pathol"},{"key":"R48-20250925","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1097\/DSS.0000000000001588","article-title":"Estimation of prognosis in invasive cutaneous melanoma: an independent study of the accuracy of a gene expression profile test","volume":"44","author":"Greenhaw","year":"2018","journal-title":"Dermatol Surg"},{"key":"R49-20250925","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/DSS.0000000000001741","article-title":"DecisionDx-melanoma and sentinel lymph node biopsy: to do or not to Do?","volume":"46","author":"Jour","year":"2020","journal-title":"Dermatol Surg"},{"key":"R50-20250925","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.sder.2004.06.002","article-title":"Surgical margins of excision for basal cell carcinoma and squamous cell carcinoma","volume":"23","author":"Huang","year":"2004","journal-title":"Semin Cutan Med Surg"},{"key":"R51-20250925","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/j.1524-4725.1997.tb00379.x","article-title":"Does the inflammation contribute to the eradication of basal cell carcinoma following curettage and electrodesiccation?","volume":"23","author":"Spencer","year":"1997","journal-title":"Dermatol Surg"},{"key":"R52-20250925","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/j.1524-4725.1989.tb03249.x","article-title":"Mohs surgery is the treatment of choice for recurrent (previously treated) basal cell carcinoma","volume":"15","author":"Rowe","year":"1989","journal-title":"J Dermatol Surg Oncol"},{"key":"R53-20250925","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1111\/dsu.12113","article-title":"Incompletely excised basal cell carcinoma: residual tumor rates at Mohs re-excision","volume":"39","author":"Palmer","year":"2013","journal-title":"Dermatol Surg"},{"key":"R54-20250925","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jaad.2018.03.060","article-title":"Basal cell carcinoma. Epidemiology; pathophysiology; clinical and histological subtypes; and disease associations","volume":"80","author":"Cameron","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"R55-20250925","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1056\/NEJMoa1113538","article-title":"Inhibiting the hedgehog pathway in patients with the basal-cell nevus syndrome","volume":"366","author":"Tang","year":"2012","journal-title":"N Engl J Med"},{"key":"R56-20250925","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1056\/NEJMoa1113713","article-title":"Efficacy and safety of vismodegib in advanced basal-cell carcinoma","volume":"366","author":"Sekulic","year":"2012","journal-title":"N Engl J Med"},{"key":"R57-20250925","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.jaad.2014.05.020","article-title":"An investigator-initiated open-label clinical trial of vismodegib as a neoadjuvant to surgery for high-risk basal cell carcinoma","volume":"71","author":"Ally","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"R58-20250925","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1097\/DSS.0000000000003207","article-title":"Use of PD-1 inhibitors in the treatment of advanced basal cell carcinoma","volume":"47","author":"Aboul-Fettouh","year":"2021","journal-title":"Dermatol Surg"},{"key":"R59-20250925","first-page":"725","article-title":"Dermoscopic features in different morphologic types of basal cell carcinoma","volume":"40","author":"Popadic","year":"2014","journal-title":"Dermatol Surg"},{"key":"R60-20250925","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1111\/j.1524-4725.1981.tb00168.x","article-title":"Squamous-cell carcinoma treated by Mohs' surgery: an experience with 414 cases in a period of 15 years","volume":"7","author":"Robins","year":"1981","journal-title":"J Dermatol Surg Oncol"},{"key":"R61-20250925","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0190-9622(92)70178-I","article-title":"Surgical margins for excision of primary cutaneous squamous cell carcinoma","volume":"27","author":"Brodland","year":"1992","journal-title":"J Am Acad Dermatol"},{"key":"R62-20250925","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1111\/j.1524-4725.2010.01576.x","article-title":"Mohs surgery is effective for high-risk cutaneous squamous cell carcinoma","volume":"36","author":"Pugliano-Mauro","year":"2010","journal-title":"Dermatol Surg"},{"key":"R63-20250925","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1111\/j.1524-4725.2012.02507.x","article-title":"Incidence of invasive squamous cell carcinomas in biopsy-proven squamous cell carcinomas in situ sent for Mohs micrographic surgery","volume":"38","author":"Chuang","year":"2012","journal-title":"Dermatol Surg"},{"key":"R64-20250925","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.jaad.2018.09.015","article-title":"Clinical outcomes in high-risk squamous cell carcinoma patients treated with Mohs micrographic surgery alone","volume":"80","author":"Marrazzo","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"R65-20250925","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.jaad.2010.08.033","article-title":"A new American Joint Committee on Cancer staging system for cutaneous squamous cell carcinoma: creation and rationale for inclusion of tumor (T) characteristics","volume":"64","author":"Farasat","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"R66-20250925","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.jaad.2012.01.010","article-title":"The 7th edition AJCC staging System for cutaneous squamous cell carcinoma accurately predicts risk of recurrence for heart and lung transplant recipients","volume":"67","author":"Metchnikoff","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"R67-20250925","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1001\/jamadermatol.2013.2456","article-title":"Evaluation of AJCC tumor staging for cutaneous squamous cell carcinoma and a proposed alternative tumor staging system","volume":"149","author":"Jambusaria-Pahlajani","year":"2013","journal-title":"JAMA Dermatol"},{"key":"R68-20250925","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1200\/JCO.2012.48.5326","article-title":"Evaluation of American Joint Committee on Cancer, International Union Against Cancer, and Brigham and Women's Hospital tumor staging for cutaneous squamous cell carcinoma","volume":"32","author":"Karia","year":"2014","journal-title":"J Clin Oncol"},{"key":"R69-20250925","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1001\/jamadermatol.2019.0032","article-title":"Performance of the American Joint Committee on cancer staging Manual, 8th edition vs the Brigham and Women's Hospital tumor classification system for cutaneous squamous cell carcinoma","volume":"155","author":"Ruiz","year":"2019","journal-title":"JAMA Dermatol"},{"key":"R70-20250925","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jaad.2017.07.031","article-title":"A new evidence-based risk stratification system for cutaneous squamous cell carcinoma into low, intermediate, and high risk groups with implications for management","volume":"78","author":"Baum","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"R71-20250925","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.jaad.2018.09.006","article-title":"Nodal staging of high-risk cutaneous squamous cell carcinoma","volume":"81","author":"Fox","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"R72-20250925","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.ejso.2006.10.017","article-title":"Sentinel lymph node biopsy for high risk cutaneous squamous cell carcinoma: case series and review of the literature","volume":"33","author":"Renzi","year":"2007","journal-title":"Eur J Surg Oncol"},{"key":"R74-20250925","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/j.1524-4725.1982.tb00317.x","article-title":"Perineural invasion by squamous-cell carcinoma","volume":"8","author":"Cottel","year":"1982","journal-title":"J Dermatol Surg Oncol"},{"key":"R75-20250925","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1111\/j.1524-4725.2009.01276.x","article-title":"Treatment of cutaneous squamous cell carcinoma with perineural invasion using Mohs micrographic surgery: report of two cases and review of the literature","volume":"35","author":"Reule","year":"2009","journal-title":"Dermatol Surg"},{"key":"R76-20250925","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/dsu.12473","article-title":"Evaluation of nerves in Mohs micrographic surgery: histologic mimickers of peri-neural invasion and nervous tissue on frozen section","volume":"40","author":"Shimizu","year":"2014","journal-title":"Dermatol Surg"},{"key":"R77-20250925","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.2165\/11205010-000000000-00000","article-title":"Cetuximab: a review of its use in squamous cell carcinoma of the head and neck","volume":"70","author":"Frampton","year":"2010","journal-title":"Drugs"},{"key":"R78-20250925","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1111\/j.1365-2133.2011.10524.x","article-title":"Systemic treatment of locally advanced nonmetastatic cutaneous squamous cell carcinoma: a review of the literature","volume":"165","author":"Behshad","year":"2011","journal-title":"Br J Dermatol"},{"key":"R79-20250925","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1056\/NEJMoa1805131","article-title":"PD-1 blockade with cemiplimab in advanced cutaneous squamous-cell carcinoma","volume":"379","author":"Migden","year":"2018","journal-title":"N Engl J Med"},{"key":"R73-20250925","doi-asserted-by":"crossref","first-page":"S118","DOI":"10.1097\/DSS.0000000000002259","article-title":"Approaches to perineural, lymphovascular and single-cell disease","volume":"45","author":"Collins","year":"2019","journal-title":"Dermatol Surg"},{"key":"R80-20250925","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/DSS.0000000000003402","article-title":"Merkel cell carcinoma, the impact of clinical excision margins and Mohs micrographic surgery on recurrence and survival: a systematic review","volume":"48","author":"Uitentuis","year":"2022","journal-title":"Dermatol Surg"},{"key":"R81-20250925","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1126\/science.1152586","article-title":"Clonal integration of a polyomavirus in human Merkel cell carcinoma","volume":"319","author":"Feng","year":"2008","journal-title":"Science"},{"key":"R82-20250925","first-page":"819","article-title":"Viral versus UV-associated merkel cell carcinoma: distinct biology, clinical behavior, and oncogenic mechanisms","volume":"137","author":"Paulson","year":"2017","journal-title":"J Invest Dermatol"},{"key":"R83-20250925","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1056\/NEJMoa1603702","article-title":"PD-1 blockade with pembrolizumab in advanced Merkel cell carcinoma","volume":"374","author":"Nghiem","year":"2016","journal-title":"N Engl J Med"},{"key":"R84-20250925","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/S1470-2045(16)30364-3","article-title":"Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial","volume":"17","author":"Kaufman","year":"2016","journal-title":"Lancet Oncol"},{"key":"R85-20250925","first-page":"726","article-title":"Retifanlimab in patients with previously treated Merkel cell carcinoma: a multicenter, international, single-arm, open-label, phase II POD1UM-201 trial","volume":"41","author":"Bhatia","year":"2023","journal-title":"J Clin Oncol"},{"key":"R87-20250925","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.1200\/JCO.23.02054","article-title":"Circulating tumor DNA assay detects Merkel cell carcinoma recurrence, disease progression, and minimal residual disease: surveillance and prognostic implications","volume":"42","author":"Akaike","year":"2024","journal-title":"J Clin Oncol"},{"key":"R88-20250925","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1097\/DSS.0000000000003601","article-title":"Mohs micrographic surgery versus wide local excision for extramammary Paget disease: a systematic review and meta-analysis","volume":"49","author":"Kim","year":"2023","journal-title":"Dermatol Surg"},{"key":"R89-20250925","first-page":"569","article-title":"Clinical and histopathologic findings of extramammary Paget disease in 41 Korean patients","volume":"35","author":"Roh","year":"2009","journal-title":"Dermatol Surg"},{"key":"R90-20250925","first-page":"59","article-title":"Mohs micrographic surgery for extramammary Paget disease: a 20-year experience and review of the literature","volume":"44","author":"Terushkin","year":"2018","journal-title":"Dermatol Surg"},{"key":"R91-20250925","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.jaad.2004.07.004","article-title":"Extramammary Paget's disease: surgical treatment with Mohs micrographic surgery","volume":"51","author":"Hendi","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"R92-20250925","first-page":"99","article-title":"Perianal extramammary Paget disease: case series and review of the literature","volume":"21","author":"Renati","year":"2023","journal-title":"World J Surg Oncol"},{"key":"R93-20250925","first-page":"507","article-title":"Urothelial carcinoma with pagetoid spread: report of a case and review of the literature","volume":"33","author":"Brown","year":"2014","journal-title":"Int J Gynecol Pathol"},{"key":"R94-20250925","first-page":"24905","article-title":"A clinicopathologic study of 100 cases of extramammary Paget disease: relevance of CK7 and CK20 expression for primary and secondary cases","volume":"7","author":"Park","year":"2016","journal-title":"Oncotarget"},{"key":"R95-20250925","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/DSS.0000000000002064","article-title":"Extramammary Paget disease: a review of the literature-part I: history, epidemiology, pathogenesis, presentation, histopathology, and diagnostic work-up","volume":"46","author":"Morris","year":"2020","journal-title":"Dermatol Surg"},{"key":"R96-20250925","doi-asserted-by":"crossref","first-page":"p354","DOI":"10.1097\/DSS.0000000000001355","article-title":"Intraoperative immunostaining for cytokeratin-7 during Mohs micrographic surgery demonstrates low local recurrence rates in extramammary Paget's disease","volume":"44","author":"Damavandy","year":"2018","journal-title":"Derm Surg"},{"key":"R97-20250925","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/1076-0512(95)00570-6","article-title":"Roentgenographic surgical margins for dermatofibrosarcoma protuberans","volume":"22","author":"Gloster","year":"1996","journal-title":"Dermatol Surg"},{"key":"R98-20250925","first-page":"640","article-title":"Determining surgical margins for dermatofibrosarcoma protuberans using preoperative imaging and postoperative histologic mapping","volume":"46","author":"Shin","year":"2020","journal-title":"Dermatol Surg"},{"key":"R99-20250925","first-page":"911","article-title":"Mohs micrographic surgery for dermatofibrosarcoma protuberans: a long-term follow-up study","volume":"23","author":"Lewis","year":"1997","journal-title":"Dermatol Surg"},{"key":"R100-20250925","first-page":"1291","article-title":"Detection of the COL1A1\u2013PDGFB fusion gene in dermatofibrosarcoma protuberans by fluorescence in situ hybridization","volume":"149","author":"Rubin","year":"1996","journal-title":"Am J Pathol"}],"container-title":["Dermatologic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/DSS.0000000000004871","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T20:00:43Z","timestamp":1758830443000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/DSS.0000000000004871"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,11]]},"references-count":99,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/dss.0000000000004871","relation":{},"ISSN":["1076-0512","1524-4725"],"issn-type":[{"type":"print","value":"1076-0512"},{"type":"electronic","value":"1524-4725"}],"subject":[],"published":{"date-parts":[[2025,9,11]]}}}